Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Novo Nordisk A/S (NVO)

48.27 -0.35 (-0.72%)

05-23 16:00

Open:

47.81

Pre. Close:

48.62

High:

48.3

Low:

47.8

Volume:

1,050,581

Market Cap:

116308M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

48.372 - 48.71

48.71 - 48.97

Low:

46.903 - 47.368

47.368 - 47.725

Close:

47.627 - 48.256

48.256 - 48.74

Technical analysis  (as of: 2018-05-23 4:30:17 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 57.07     One year: 58.76

Support:

Support1: 46.52    Support2: 38.70

Resistance:

Resistance1: 48.86    Resistance2: 50.31

Pivot:

48.52

Moving Averages:

MA(5): 48.66     MA(20): 48.30

MA(100): 50.98     MA(250): 48.70

MACD:

MACD(12,26):     Signal(12,26,9): -0.07

%K %D:

%K(14,3): 40.20     %D(3): 47.08

RSI:

RSI(14): 47.57

52-Week:

High: 58.37  Low: 41.03  Change(%): 15.3

Average Vol(K):

3-Month: 136975  10-Days 114975

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NVO has closed above bottom band by 38.9%. Bollinger Bands are 53.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to NVO's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-21T11:57:48-04:00
A Quantitative System To Invest In Quality Stocks

2018-05-18T08:21:17-04:00
Investors bullish on biotechs after Trump drug pricing speech

2018-05-14T12:16:36-04:00
Provention Bio Files For Up To $50 Million IPO

2018-05-11T14:25:19-04:00
Trump speech on drug prices light on specifics

2018-05-11T10:22:19-04:00
Trump plan on drug prices to be announced this afternoon

2018-05-10T06:28:18-04:00
Novo Nordisk: Review Of Key Growth Drivers And Pipeline Candidates

2018-05-08T10:48:26-04:00
Novo Nordisk: An Objective Analysis

2018-05-08T07:41:19-04:00
Emisphere's Solid Future

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

2428.67

Shares Float (M)

2428.67

% Held by Insiders

% Held by Institutions

6.60

Shares Short (K)

2148

Shares Short Prior Month (K)

4010

Stock Financials

EPS

2.320

EPS Est. Current Year

2.420

EPS Est. Next Year

2.590

EPS Est. Next Quarter

0.530

Forward EPS

2.780

Book Value (p.s.)

16.630

PEG Ratio

2.47

Profit Margin

18.04

Operating Margin

43.68

Return on Assets (ttm)

41.3

Return on Equity (ttm)

91.6

Qtrly Rev. Growth

-5.3

Gross Profit (p.s.)

5.957

Sales Per Share

EBITDA (p.s.)

3.422

Qtrly Earnings Growth

5.90

Operating Cash Flow (M)

6410.00

Levered Free Cash Flow (M)

2870.00

atoplab.com

Valuation

P/E

20.81

P/E Growth Ratio

-0.01

P/BV

2.90

P/S

16133545984.00

P/CF

18.29

Dividend Yield

0.07

Dividends & Splits

Dividend

3.284

Dividend Pay Date

2018-04-03

Ex-Dividend Date

2018-03-23

Forward Dividend

1.280

Last Split Date

2014-01-09

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.